Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

FDC Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

FDC şirketinin toplam hissedar öz sermayesi ₹21.0B ve toplam borcu ₹205.2M olup, bu da borç-öz sermaye oranını 1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹24.7B ve ₹3.7B dir. FDC 'in FAVÖK'ü ₹3.2B faiz karşılama oranı 75.2 dur. Şirketin ₹4.8B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

1.0%

Borç/özkaynak oranı

₹205.19m

Borç

Faiz karşılama oranı	75.2x
Nakit	₹4.76b
Eşitlik	₹20.97b
Toplam yükümlülükler	₹3.71b
Toplam varlıklar	₹24.68b

Son finansal sağlık güncellemeleri

FDC (NSE:FDC) Seems To Use Debt Quite Sensibly

Sep 15

Recent updates

Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' Concerns

Sep 16

A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)

May 13

Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)

Nov 18

Here's Why I Think FDC (NSE:FDC) Is An Interesting Stock

Aug 20

FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their Numbers

May 29

Here's Why We Think FDC (NSE:FDC) Is Well Worth Watching

Apr 30

What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?

Mar 11

If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% Returns

Feb 21

Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?

Feb 06

With EPS Growth And More, FDC (NSE:FDC) Is Interesting

Jan 19

FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend Stock

Dec 29

Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?

Dec 08

The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For More

Nov 12

Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?

Oct 22

Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?

Oct 01

Estimating The Fair Value Of FDC Limited (NSE:FDC)

Sep 10

What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?

Aug 20

What You Can Learn From FDC Limited's (NSE:FDC) P/E

Jul 25

Is FDC Limited's (NSE:FDC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jul 07

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: FDC 'nin kısa vadeli varlıkları ( ₹10.7B ) kısa vadeli yükümlülüklerini ( ₹3.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: FDC şirketinin kısa vadeli varlıkları ( ₹10.7B ) uzun vadeli yükümlülüklerini ( ₹603.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: FDC şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: FDC şirketinin borç/öz sermaye oranı son 5 yılda 0.03% seviyesinden 1% seviyesine yükseldi.

Borç Kapsamı: FDC 'nin borcu işletme nakit akışı ( 1075.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: FDC 'in borcuna ilişkin faiz ödemeleri EBIT ( 75.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

FDC Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

FDC (NSE:FDC) Seems To Use Debt Quite Sensibly

Recent updates

Why We Think FDC Limited's (NSE:FDC) CEO Compensation Is Not Excessive At All

There's Reason For Concern Over FDC Limited's (NSE:FDC) Massive 30% Price Jump

FDC Limited Announces Cessation of CA Swati Sandesh Mayekar as Non-Independent Director

FDC Limited, Annual General Meeting, Sep 26, 2024

Here's Why We Think FDC (NSE:FDC) Might Deserve Your Attention Today

First quarter 2025 earnings released: EPS: ₹7.31 (vs ₹6.62 in 1Q 2024)

FDC Limited to Report Q1, 2025 Results on Aug 07, 2024

There Is A Reason FDC Limited's (NSE:FDC) Price Is Undemanding

Full year 2024 earnings released: EPS: ₹18.58 (vs ₹11.67 in FY 2023)

FDC Limited Announces Board Completion of Tenure of Independent Directors

FDC Limited's (NSE:FDC) Price Is Right But Growth Is Lacking

Third quarter 2024 earnings released: EPS: ₹4.86 (vs ₹2.45 in 3Q 2023)

Second quarter 2024 earnings released: EPS: ₹4.22 (vs ₹3.10 in 2Q 2023)

Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped Up

FDC (NSE:FDC) Seems To Use Debt Quite Sensibly

FDC Limited to Report Fiscal Year 2024 Results on May 29, 2024

FDC Limited, Annual General Meeting, Sep 27, 2023

FDC Limited (BSE:531599) agreed to acquire remaining 7% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. from other existing shareholders.

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: ₹6.62 (vs ₹4.23 in 1Q 2023)

FDC Limited to Report Q1, 2024 Results on Aug 09, 2023

Full year 2023 earnings released: EPS: ₹11.66 (vs ₹12.82 in FY 2022)

Third quarter 2023 earnings released: EPS: ₹2.45 (vs ₹2.11 in 3Q 2022)

FDC Limited to Report Q3, 2023 Results on Feb 09, 2023

Second quarter 2023 earnings released: EPS: ₹3.10 (vs ₹4.28 in 2Q 2022)

Price target increased to ₹375

FDC Limited Approves Appointment of Vijay S. Maniar as an Non-Executive and Independent Director

Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' Concerns

FDC Limited to Report Q4, 2023 Results on May 23, 2023

First quarter 2023 earnings released: EPS: ₹4.23 (vs ₹5.80 in 1Q 2022)

FDC Limited to Report Q1, 2023 Results on Aug 04, 2022

Board Member recently bought ₹912k worth of stock

Insufficient new directors

Full year 2022 earnings: EPS and revenues miss analyst expectations

FDC Limited to Report Q4, 2022 Results on May 25, 2022

A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)

Price target decreased to ₹415

Fdc Limited Announces That Nomita R. Chandavarkar Has Stepped Down from the Position of the Executive Director of the Company to Non-Executive Director with Effect from April 01, 2022

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

FDC Limited (BSE:531599) announces an Equity Buyback for 2,900,000 shares, representing 1.72% for INR 1,377.5 million.

Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)

Second quarter 2022 earnings released: EPS ₹4.28 (vs ₹5.15 in 2Q 2021)

Price target decreased to ₹415

Here's Why I Think FDC (NSE:FDC) Is An Interesting Stock

First quarter 2022 earnings released: EPS ₹5.80 (vs ₹5.36 in 1Q 2021)

FDC Limited Launches Favipiravir Oral Suspension -Favenza

Investor sentiment improved over the past week

FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their Numbers

Full year 2021 earnings released: EPS ₹17.72 (vs ₹13.94 in FY 2020)

Here's Why We Think FDC (NSE:FDC) Is Well Worth Watching

What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?

If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% Returns

Price target raised to ₹470

Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?

Third quarter 2021 earnings released: EPS ₹4.47 (vs ₹4.31 in 3Q 2020)

New 90-day low: ₹288

FDC Limited to Report Q3, 2021 Results on Feb 04, 2021

New 90-day low: ₹312

With EPS Growth And More, FDC (NSE:FDC) Is Interesting

FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend Stock

Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?

The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For More

Second quarter 2021 earnings released: EPS ₹5.15

Revenue and earnings beat expectations

Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?

New 90-day high: ₹367

Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?

New 90-day high - ₹349

FDC Limited to Report Q1, 2021 Results on Aug 07, 2020

Estimating The Fair Value Of FDC Limited (NSE:FDC)

What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?

FDC Limited (BSE:531599) entered into definitive agreements to acquire an additional 44% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd from Pharma-Q Holdings Pty for ZAR 0.14 million.

First quarter earnings released

FDC Limited (BSE:531599) entered into definitive agreements to acquire an additional 44% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd from Pharma-Q Holdings Pty for ZAR 0.14 million.